Company guide

Corporate philosophy

The healthy function of our body is maintained by systematic differentiation of cells forming tissue and organs according to the plan of gene expression written in our DNA.
However, cancer may form by disordered proliferation of a cell when critical genes are altered by the environment and/or our life habit. The latest statistics estimate that one in two people get cancer, and one in four males and one in six females die of cancer in Japan.
Early-stage cancer may be cured completely by standard therapy under health insurance.
On the other hand, there may be no standard therapy for advanced cancer.
We think that patients have a right to decide whether to take an advanced therapy to live longer while keeping the quality of life. However, it is not easy for patients to decide whether to take advanced therapies due to little information about the treatment.
Therefore, we would like to help cancer patients by researching safe and effective advanced therapies, performing technical cooperation with clinics, and properly advising cancer patients.

Overview

Company name International Cancer Laboratory Co., Ltd.
Office address Tokyo, Japan
Foundation date 13 August, 2021
Capital stock 9,000,000 Yen
Description of business 1.Research and development of the prevention, examination, and treatment of cancer
2.Technical cooperation on the prevention, examination, and treatment of cancer
3.International cooperation on the prevention, examination, and treatment of cancer
CEO Norio Takeuchi
Business associate Imugene (Australia)
Almac (UK)
Neues (Japan)
Seppic (France)
Bank accounts Mizuho Bank,
The Higashi-Nippon Bank,
Rakuten Bank